Sumitomo Pharma Co., Ltd. (TYO:4506)

Japan · Delayed Price · Currency is JPY

1,562.50

-57.50 (-3.55%)

May 19, 2026, 2:15 PM JST

Revenue by Segment

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
Pharmaceuticals - Japan	92.37B	99.84B	114.66B	126.16B	149.98B
Pharmaceuticals - Japan Growth	-7.49%	-12.92%	-9.12%	-15.88%	-1.70%
Pharmaceuticals - North America	337.92B	251.81B	159.04B	328.47B	319.79B
Pharmaceuticals - North America Growth	34.20%	58.34%	-51.58%	2.71%	13.60%
Pharmaceuticals - Asia	23.01B	47.18B	40.86B	-	-
Pharmaceuticals - Asia Growth	-51.24%	15.46%	-	-	-
Pharmaceuticals - China	-	-	-	39.40B	38.30B
Pharmaceuticals - China Growth	-	-	-	2.87%	37.60%
Pharmaceuticals - Other Overseas	-	-	-	16.75B	12.18B
Pharmaceuticals - Other Overseas Growth	-	-	-	37.58%	-29.34%
Other Business	-	-	-	44.88B	39.90B
Other Business Growth	-	-	-	12.50%	8.00%
Elimination of Intersegment Transactions	-	-	-	-120.00M	-101.00M
Total	453.29B	398.83B	314.56B	555.54B	560.04B
Total Growth	13.66%	26.79%	-43.38%	-0.80%	8.54%

Revenue by Geography

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017
Japan	84.77B	92.59B	107.34B	170.61B	222.88B
Japan Growth	-8.45%	-13.74%	-37.08%	-23.45%	15.72%
North America (Excl. United States)	1.88B	2.46B	2.63B	3.20B	4.77B
North America (Excl. United States) Growth	-23.57%	-6.39%	-17.92%	-32.82%	-1.55%
United States of America	320.66B	243.55B	152.55B	325.89B	282.52B
United States of America Growth	31.66%	59.65%	-53.19%	15.35%	2.51%
Others (Excl. China)	26.64B	18.48B	18.24B	-	-
Others (Excl. China) Growth	44.18%	1.33%	-	-	-
China	19.34B	41.75B	33.80B	-	-
China Growth	-53.68%	23.55%	-	-	-
Others	-	-	-	55.84B	49.86B
Others Growth	-	-	-	12.00%	16.21%
Total	453.29B	398.83B	314.56B	555.54B	560.04B
Total Growth	13.66%	26.79%	-43.38%	-0.80%	8.54%

Source: S&P Global Market Intelligence.